What’s Happening? Koh Young’s Upcoming IR Meeting

Koh Young will hold an IR meeting for domestic and international analysts on August 6th. The meeting will cover recent business performance, financial results, and a Q&A session to address investor inquiries.

Why is Koh Young Important? Q1 Results and Future Growth Drivers

In Q1 2025, Koh Young maintained robust profitability despite a decrease in sales. However, declining orders from smartphone clients raise concerns. The medical robot business, a key future growth driver, is still in its early stages, requiring time to achieve profitability. This IR meeting is expected to provide clarity on Q2 results and future outlook.

So, What’s Next? Key IR Insights and Investment Points

  • Q2 and H1 2025 Results: Sales recovery and profit margin maintenance
  • 3D AOI & 3D SPI Business Outlook: Market share target achievement, new product launch plans
  • Medical Robot Business Progress: KYMERO’s US market entry status, post-FDA approval market response, profitability strategy
  • Future Sales Outlook: 2025 annual sales forecast and mid-to-long-term growth strategy
  • Financial Strategy: Funding plans for R&D investment, debt management strategy

External factors such as exchange rates, interest rates, raw material prices, and the Chinese economic situation should also be considered.

What Should Investors Do? Analyze IR Outcomes and Develop Investment Strategies

Investors should carefully analyze the information presented at the IR meeting to formulate their investment strategies. Pay close attention to the performance of the medical robot business and Koh Young’s response to changes in the smartphone market.